A detailed history of New Edge Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 15,723 shares of VTRS stock, worth $181,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,723
Previous 21,192 25.81%
Holding current value
$181,600
Previous $253,000 33.99%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$10.05 - $12.02 $54,963 - $65,737
-5,469 Reduced 25.81%
15,723 $167,000
Q1 2024

May 14, 2024

SELL
$11.27 - $13.53 $17,908 - $21,499
-1,589 Reduced 6.98%
21,192 $253,000
Q4 2023

Feb 13, 2024

BUY
$8.77 - $10.85 $5,112 - $6,325
583 Added 2.63%
22,781 $246,000
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $3,797 - $4,494
-396 Reduced 1.75%
22,198 $218,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $631 - $720
-70 Reduced 0.31%
22,594 $225,000
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $50,425 - $67,197
5,481 Added 31.9%
22,664 $218,000
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $149,835 - $198,635
17,183 New
17,183 $191,000
Q2 2022

Aug 09, 2022

BUY
$9.95 - $12.27 $2,268 - $2,797
228 Added 1.14%
20,289 $213,000
Q1 2022

May 13, 2022

BUY
$9.81 - $15.4 $5,993 - $9,409
611 Added 3.14%
20,061 $219,000
Q4 2021

Feb 17, 2022

BUY
$12.09 - $14.68 $235,150 - $285,526
19,450 New
19,450 $263,000
Q3 2021

Oct 29, 2021

SELL
$13.25 - $15.13 $191,025 - $218,129
-14,417 Closed
0 $0
Q2 2021

Jul 22, 2021

BUY
$12.97 - $16.15 $10,038 - $12,500
774 Added 5.67%
14,417 $206,000
Q1 2021

Apr 26, 2021

SELL
$13.59 - $18.54 $47,918 - $65,372
-3,526 Reduced 20.54%
13,643 $191,000
Q4 2020

Jan 27, 2021

BUY
$14.3 - $18.74 $245,516 - $321,747
17,169 New
17,169 $322,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.